gary2d ago

https://www.nextplatform.com/hpc/2026/05/06/cleveland-clinic-simulates-large-proteins-with-quantum-centric-supercomputing/5219579

quantum computers can be networked now, more usable qubits will be able to be connected

more 'breakthroughs' will end up happening, things go slow at the start

#ibm #cleveland clinic #folding #enzymes #trypsin #catalysts #sims #merck index #buffer systems #chirality #nextplatform.com

Cleveland Clinic Simulates Large Proteins With Quantum-Centric Supercomputing

nextplatform
Ken Everett (Ken's Blogspot)Apr 30

#Merck beats quarterly estimates on strength of Keytruda -
https://kensbookinfo.blogspot.com/p/business.html#40

I switched from #Samsung Messages to #Google Messages -
https://kensbookinfo.blogspot.com/p/infotech.html#25

#Football fever returns to #Qatar after FIFA confirms -
https://kensbookinfo.blogspot.com/p/etc-continents.html#Europe

Exports fall in #Portugal while imports rise -
https://kensbookinfo.blogspot.com/p/world-capitals.html#Lisbon

#UAE oil exit from #OPEC signals focus on domestic priorities -
https://kensbookinfo.blogspot.com/p/world-capitals.html#Riyadh

View all the latest breaking news https://kensbookinfo.blogspot.com/2026/03/latest-breaking-news.html

Business

The latest news and headlines, featuring real time updates for countries, cities, states, politics, economy, sports, food, culture via Ken's Blogspot

Beth PariseauApr 23

Blue chip companies including #Merck, #Citi and #HomeDepot will expand use of #Google #Gemini Enterprise #AI agents on a revamped platform, but how far its appeal will extend beyond the #GoogleCloud user base remains to be seen.

My writeup features comments from interviews and sessions at #GoogleCloudNext:

https://www.techtarget.com/searchitoperations/news/366642097/Merck-Home-Depot-tap-Gemini-Enterprise-for-AI-agent-development

Merck, Home Depot tap Gemini Enterprise for AI agent development

Blue chips will expand use of Gemini Enterprise AI agents on a revamped platform, but how far its appeal will extend beyond the Google Cloud user base remains to be seen.

TechTarget
Analyst207Apr 22

Merck Strikes $1B AI Deal with Google Cloud to Transform Drug R&D

Merck is shaking up the future of drug research and development with a groundbreaking $1 billion deal with Google Cloud, harnessing the power of artificial intelligence to speed up scientific breakthroughs and bring life-changing treatments to patients faster. By combining forces, they'll create an AI-enabled enterprise that…

https://osintsights.com/merck-strikes-1b-ai-deal-with-google-cloud-to-transform-drug-rd?utm_source=mastodon&utm_medium=social

#ArtificialIntelligence #GoogleCloud #Merck #Pharmaceutical #Healthcare

Merck Strikes $1B AI Deal with Google Cloud to Transform Drug R&D

Merck partners with Google Cloud on $1B AI deal to revolutionize drug R&D with agentic AI, discover how this game-changing tech can accelerate breakthroughs.

OSINTSights
Jens JoachimApr 16
🟪🧩 Lila Container soll neugierig machen 🟪🧩
In einem mobilen Wissenschaftslabor der Firma #Merck in #Darmstadt können Grundschulklassen experimentieren.
https://www.fr.de/rhein-main/darmstadt/lila-container-auf-dem-merck-gelaende-in-darmstadt-soll-neugierig-machen-94262081.html
@FR #FRDarmstadt #FediLZ #FediLZDA #Grundschule #MINT #Naturwissenschaft #Bildung #Unterricht
Lila Container auf dem Merck-Gelände in Darmstadt soll neugierig machen

In einem mobilen Wissenschaftslabor der Firma Merck in Darmstadt können Grundschulklassen experimentieren.

Paradis Fiscaux et JudiciairesApr 14

#Merck #multinationalCompanies #taxheaven
Aux Pays-Bas, les multinationales bénéficient toujours d’avantages fiscaux considérables, révèle une enquête

https://www.icij.org/investigations/cancer-calculus/merck-keytruda-cancer-drug-price/

How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide - ICIJ

The pharmaceutical giant has built a fortress of patents, traded in secrecy and relentlessly lobbied to guard its revenue kingpin Keytruda.

International Consortium of Investigative Journalists
elDiarioAR.com [Unofficial]Apr 13

Patentes contra el cáncer: el "caso argentino" que forzó al gigante Merck a bajar el precio de su medicamento estrella

https://web.brid.gy/r/https://www.eldiarioar.com/sociedad/patentes-cancer-caso-argentino-forzo-gigante-merck-bajar-precio-medicamento-estrella_1_13135917.html

Industry ExaminerMar 26

Merck’s $6.7B Terns buy is less about leukemia than life after Keytruda.

When one drug drives nearly half of revenue, M&A becomes a way to buy time before the patent cliff.

Read:
https://biotech.industryexaminer.com/merck-terns-deal-keytruda-patent-cliff-biotech-m-and-a/

#Biotech #Pharma #Merck #Oncology #PatentCliff #BiotechM&A #TechNews #BioTechne

Merck’s $6.7 billion Terns deal is really a bet on life after Keytruda - Biotech Industry Examiner

The target is a leukemia drug developer. The real objective is something larger: time, diversification, and a more believable post-Keytruda growth story.

Biotech Industry Examiner
Ken Everett (Ken's Blogspot)Mar 2

How #LockheedMartin Fighters Stack Up Against Each
https://kensbookinfo.blogspot.com/p/science.html#12

A #Merck cancer drug to watch
https://kensbookinfo.blogspot.com/p/business.html#43

Michael Scott, the company's first #CEO, made bold and
https://kensbookinfo.blogspot.com/p/infotech.html#49

#Israel Supreme Court freezes foreign aid organizations
https://kensbookinfo.blogspot.com/p/canada.html13

Is it safe to travel to #Jordan? Latest travel advice
https://kensbookinfo.blogspot.com/p/etc.html#Jordan

#Wisconsin women's hockey stays atop national rankings
https://kensbookinfo.blogspot.com/p/us-capitals.html#Madison

Science

The latest news and headlines, featuring real time updates for countries, cities, states, politics, economy, sports, food, culture via Ken's Blogspot

Yonhap Infomax NewsFeb 3
Merck & Co. shares slipped after the pharmaceutical giant issued annual guidance below market expectations, citing Trump-era drug price cuts and patent expirations.
#YonhapInfomax #Merck #AnnualGuidance #DrugPriceCuts #EarningsPerShare #PatentExpiration #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103670
Merck Shares Fall 1.5% as Annual Guidance Misses Expectations—Trump-Driven Drug Price Cuts Weigh

Merck & Co. shares slipped after the pharmaceutical giant issued annual guidance below market expectations, citing Trump-era drug price cuts and patent expirations.

Yonhap Infomax